Ligand Pharmaceuticals Launches Pelthos to Accelerate Commercialization of Zelsuvmi for Molluscum; Appoints New CEO April 3, 2024
Skin Biomarkers May Predict Early Risk of Food Allergies or AD in Infants; Prevention Trial Underway March 29, 2024
Verrica Pharmaceuticals’ YCANTH Receives New Chemical Entity Status, Orange Book Listing From FDA March 26, 2024
Dr. Lawrence Eichenfield Unpacks New Phase 3 Data on Roflumilast Cream 0.05% in AD in Kids Aged 2 to 5 March 12, 2024